{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:09:21Z","timestamp":1792469361573,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41584-026-01394-2","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:16:00Z","timestamp":1781795760000},"page":"558-570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lung disease in rheumatoid arthritis"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4238-6963","authenticated-orcid":false,"given":"Elisabeth","family":"Bendstrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4814-0307","authenticated-orcid":false,"given":"Philippe","family":"Dieude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-7422","authenticated-orcid":false,"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5591-0955","authenticated-orcid":false,"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2562-9174","authenticated-orcid":false,"given":"Ellen M.","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"1394_CR1","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo, A., Bathon, J. M. & Emery, P. Rheumatoid arthritis. Lancet 402, 2019\u20132033 (2023).","journal-title":"Lancet"},{"key":"1394_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4314-9","volume":"37","author":"BR England","year":"2018","unstructured":"England, B. R. et al. Chronic lung disease in U.S. veterans with rheumatoid arthritis and the impact on survival. Clin. Rheumatol. 37, 2907 (2018).","journal-title":"Clin. Rheumatol."},{"key":"1394_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.01312-2024","volume":"11","author":"A Froidure","year":"2025","unstructured":"Froidure, A. et al. Lung involvement in rheumatoid arthritis, a prospective study. ERJ Open Res. 11, 01312-2024 (2025).","journal-title":"ERJ Open Res."},{"key":"1394_CR4","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/art.42961","volume":"76","author":"RT Brooks","year":"2024","unstructured":"Brooks, R. T. et al. The risk of lung cancer in rheumatoid arthritis and rheumatoid arthritis\u2013associated interstitial lung disease. Arthritis Rheumatol. 76, 1730\u20131738 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1394_CR5","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s10067-023-06589-6","volume":"42","author":"F Fareez","year":"2023","unstructured":"Fareez, F., Moodley, J., Popovic, S. & Lu, J. Q. Rheumatoid nodules: a narrative review of histopathological progression and diagnostic consideration. Clin. Rheumatol. 42, 1753\u20131765 (2023).","journal-title":"Clin. Rheumatol."},{"key":"1394_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2559.2004.01896.x","volume":"44","author":"D Tansey","year":"2004","unstructured":"Tansey, D. et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 44, 585\u2013596 (2004).","journal-title":"Histopathology"},{"key":"1394_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/art.30077","volume":"63","author":"V Cottin","year":"2011","unstructured":"Cottin, V. et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum. 63, 295\u2013304 (2011).","journal-title":"Arthritis Rheum."},{"key":"1394_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10067-020-05320-z","volume":"40","author":"Y Dai","year":"2021","unstructured":"Dai, Y., Wang, W., Yu, Y. & Hu, S. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management. Clin. Rheumatol. 40, 1211\u20131220 (2021).","journal-title":"Clin. Rheumatol."},{"key":"1394_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2016","unstructured":"Agca, R. et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann. Rheum. Dis. 76, 17\u201328 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1394_CR10","volume":"67","author":"KM Antonious","year":"2026","unstructured":"Antonious, K. M. et al. ERS\/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. Eur. Respir. J. 67, 2500896 (2026).","journal-title":"Eur. Respir. J."},{"key":"1394_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.rmed.2018.06.010","volume":"140","author":"C Hyldgaard","year":"2018","unstructured":"Hyldgaard, C. et al. Increased mortality among patients with rheumatoid arthritis and COPD: a population-based study. Respir. Med. 140, 101\u2013107 (2018).","journal-title":"Respir. Med."},{"key":"1394_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0248-2024","volume":"34","author":"Y Kluanwan","year":"2025","unstructured":"Kluanwan, Y., Tangnuntachai, N., Ryu, J. H. & Moua, T. Bronchiolar disorders in systemic autoimmune rheumatic diseases. Eur. Respir. Rev. 34, 240248 (2025).","journal-title":"Eur. Respir. Rev."},{"key":"1394_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1403851","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y., Wang, W., Zhou, D. & Li, L. The causal relationship between rheumatoid arthritis and bronchiectasis: a bidirectional Mendelian randomization study. Front. Med. 11, 1403851 (2024).","journal-title":"Front. Med."},{"key":"1394_CR14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.chest.2024.02.014","volume":"165","author":"C Chung","year":"2024","unstructured":"Chung, C. et al. Does rheumatoid arthritis increase the risk of COPD?: a nationwide retrospective cohort study. Chest 165, 1362\u20131371 (2024).","journal-title":"Chest"},{"key":"1394_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1164\/rccm.202204-0671PP","volume":"206","author":"B Celli","year":"2022","unstructured":"Celli, B. et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am. J. Respir. Crit. Care Med. 206, 1317\u20131325 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1394_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.chest.2024.09.006","volume":"167","author":"SM Matson","year":"2025","unstructured":"Matson, S. M. et al. Airways abnormalities in a prospective cohort of patients with rheumatoid arthritis. Chest 167, 495\u2013506 (2025).","journal-title":"Chest"},{"key":"1394_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1624223","volume":"16","author":"T Kang","year":"2025","unstructured":"Kang, T. et al. The risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a real-world cohort study from 136,821 patients. Front. Immunol. 16, 1624223 (2025).","journal-title":"Front. Immunol."},{"key":"1394_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66479-8","volume":"10","author":"G Ryu","year":"2020","unstructured":"Ryu, G., Min, C., Park, B., Choi, H. G. & Mo, J. H. Bidirectional association between asthma and chronic rhinosinusitis: two longitudinal follow-up studies using a national sample cohort. Sci. Rep. 10, 9589 (2020).","journal-title":"Sci. Rep."},{"key":"1394_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.semarthrit.2020.07.015","volume":"50","author":"N Charoenngam","year":"2020","unstructured":"Charoenngam, N. et al. Patients with asthma have a higher risk of rheumatoid arthritis: a systematic review and meta-analysis. Semin. Arthritis Rheum. 50, 968\u2013976 (2020).","journal-title":"Semin. Arthritis Rheum."},{"key":"1394_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/acr.25193","volume":"77","author":"J Yan","year":"2025","unstructured":"Yan, J. et al. Increased risk of rheumatoid arthritis in patients with asthma: a genetic association study using two-sample Mendelian randomization analysis. Arthritis Care Res. 77, 178\u2013184 (2025).","journal-title":"Arthritis Care Res."},{"key":"1394_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43481-3","volume":"9","author":"SY Kim","year":"2019","unstructured":"Kim, S. Y., Min, C., Oh, D. J. & Choi, H. G. Increased risk of asthma in patients with rheumatoid arthritis: a longitudinal follow-up study using a national sample cohort. Sci. Rep. 9, 6957 (2019).","journal-title":"Sci. Rep."},{"key":"1394_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4168\/aair.2023.15.5.647","volume":"15","author":"IH Lee","year":"2023","unstructured":"Lee, I. H. et al. Effect of chronic rhinosinusitis on the risk of development of rheumatoid arthritis. Allergy Asthma Immunol. Res. 15, 647\u2013658 (2023).","journal-title":"Allergy Asthma Immunol. Res."},{"key":"1394_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2147\/JAA.S484402","volume":"17","author":"Y Yuan","year":"2024","unstructured":"Yuan, Y., Wu, Z., Chen, X. & Xie, B. Rheumatoid arthritis exacerbates eosinophilic inflammation contributing to postoperative recurrence in chronic rhinosinusitis with nasal polyps. J. Asthma Allergy 17, 901\u2013910 (2024).","journal-title":"J. Asthma Allergy"},{"key":"1394_CR24","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s10067-018-4114-2","volume":"37","author":"Y Luo","year":"2018","unstructured":"Luo, Y. et al. Rheumatoid arthritis is associated with increased in-hospital mortality in asthma exacerbations: a nationwide study. Clin. Rheumatol. 37, 1971\u20131976 (2018).","journal-title":"Clin. Rheumatol."},{"key":"1394_CR25","unstructured":"Global Initiative for Chronic Obstructive Lung Disease \u2014 GOLD. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2024 report) https:\/\/goldcopd.org\/2024-gold-report\/# (2024)."},{"key":"1394_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/03009742.2025.2603046","volume":"55","author":"C Hyldgaard","year":"2026","unstructured":"Hyldgaard, C. et al. Chronic obstructive pulmonary disease and rheumatoid arthritis: severe exacerbations, pneumonia, and death in a population-based cohort. Scand. J. Rheumatol. 55, 163\u2013171\u00a0(2026).","journal-title":"Scand. J. Rheumatol."},{"key":"1394_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9060604","volume":"9","author":"CM Bergs\u00f8e","year":"2021","unstructured":"Bergs\u00f8e, C. M. et al. Risk of chronic obstructive pulmonary disease exacerbation in patients who use methotrexate \u2014 a nationwide study of 58,580 outpatients. Biomedicines 9, 604 (2021).","journal-title":"Biomedicines"},{"key":"1394_CR28","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1183\/09031936.00091608","volume":"33","author":"G Devouassoux","year":"2009","unstructured":"Devouassoux, G. et al. Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur. Respir. J. 33, 1053\u20131061 (2009).","journal-title":"Eur. Respir. J."},{"key":"1394_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1378\/chest.85.5.705","volume":"85","author":"A Lahdensuo","year":"1984","unstructured":"Lahdensuo, A., Mattila, J. & Vilppula, A. Bronchiolitis in rheumatoid arthritis. Chest 85, 705\u2013708 (1984).","journal-title":"Chest"},{"key":"1394_CR30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/art.1780240318","volume":"24","author":"KC Murphy","year":"1981","unstructured":"Murphy, K. C., Atkins, C. J., Offer, R. C., Hogg, J. C. & Stein, H. B. Obliterative bronchiolitis in two rheumatoid arthritis patients treated with penicillamine. Arthritis Rheum. 24, 557\u2013560 (1981).","journal-title":"Arthritis Rheum."},{"key":"1394_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0673-x","volume":"18","author":"E Lin","year":"2018","unstructured":"Lin, E., Limper, A. H. & Moua, T. Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series. BMC Pulm. Med. 18, 105 (2018).","journal-title":"BMC Pulm. Med."},{"key":"1394_CR32","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1164\/ajrccm.154.5.8912776","volume":"154","author":"H Hayakawa","year":"1996","unstructured":"Hayakawa, H. et al. Bronchiolar disease in rheumatoid arthritis. Am. J. Respir. Crit. Care Med. 154, 1531\u20131536 (1996).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1394_CR33","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","volume":"151","author":"A De Soyza","year":"2017","unstructured":"De Soyza, A. et al. Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study. Chest 151, 1247\u20131254 (2017).","journal-title":"Chest"},{"key":"1394_CR34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232558","volume":"310","author":"AA Bankier","year":"2024","unstructured":"Bankier, A. A. et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 310, e232558 (2024).","journal-title":"Radiology"},{"key":"1394_CR35","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.chest.2024.01.001","volume":"165","author":"H Choi","year":"2024","unstructured":"Choi, H. et al. Impact of rheumatoid arthritis and seropositivity on the risk of non-cystic fibrosis bronchiectasis. Chest 165, 1330\u20131340 (2024).","journal-title":"Chest"},{"key":"1394_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.semarthrit.2021.08.005","volume":"51","author":"LW Martin","year":"2021","unstructured":"Martin, L. W. et al. Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: a systematic review and meta-analysis. Semin. Arthritis Rheum. 51, 1067\u20131080 (2021).","journal-title":"Semin. Arthritis Rheum."},{"key":"1394_CR37","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.34344","volume":"64","author":"MK Demoruelle","year":"2012","unstructured":"Demoruelle, M. K. et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum. 64, 1756\u20131761 (2012).","journal-title":"Arthritis Rheum."},{"key":"1394_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215051","volume":"14","author":"K Makin","year":"2019","unstructured":"Makin, K. et al. Undetectable mannose binding lectin is associated with HRCT proven bronchiectasis in rheumatoid arthritis (RA). PLoS ONE 14, 4 (2019).","journal-title":"PLoS ONE"},{"key":"1394_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/ar2913","volume":"12","author":"O Elkayam","year":"2010","unstructured":"Elkayam, O. et al. The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment. Arthritis Res. Ther. 12, 1 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"1394_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur, R. et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med. 5, 178ra40 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1394_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/1479973121994565","volume":"18","author":"R Wiater","year":"2021","unstructured":"Wiater, R., H\u00e5kansson, K. E. J. & Ulrik, C. S. A causal relationship between rheumatoid arthritis and bronchiectasis? A systematic review and meta-analysis. Chron. Respir. Dis. 18, 1479973121994565 (2021).","journal-title":"Chron. Respir. Dis."},{"key":"1394_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jbspin.2019.12.006","volume":"87","author":"AC Duarte","year":"2020","unstructured":"Duarte, A. C., Porter, J. & Leandro, M. J. Bronchiectasis in rheumatoid arthritis. A clinical appraisal. Jt Bone Spine 87, 419\u2013424 (2020).","journal-title":"Jt Bone Spine"},{"key":"1394_CR43","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","volume":"392","author":"JD Chalmers","year":"2025","unstructured":"Chalmers, J. D. et al. Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N. Engl. J. Med. 392, 1569\u20131581 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1394_CR44","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"P-A Juge","year":"2018","unstructured":"Juge, P.-A. et al. MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N. Engl. J. Med. 379, 2209\u20132219 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1394_CR45","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1136\/annrheumdis-2021-220698","volume":"80","author":"A Palom\u00e4ki","year":"2021","unstructured":"Palom\u00e4ki, A. et al. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers. Ann. Rheum. Dis. 80, 1530\u20131536 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1394_CR46","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","volume":"364","author":"MA Seibold","year":"2011","unstructured":"Seibold, M. A. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364, 1503\u20131512 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1394_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.106943","volume":"201","author":"JG Natalini","year":"2022","unstructured":"Natalini, J. G. et al. Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. veterans. Respir. Med. 201, 106943 (2022).","journal-title":"Respir. Med."},{"key":"1394_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/thorax-2023-220022","volume":"79","author":"TJ Doyle","year":"2024","unstructured":"Doyle, T. J. et al. Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax 79, 182\u2013185 (2024).","journal-title":"Thorax"},{"key":"1394_CR49","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","volume":"53","author":"CA Kelly","year":"2014","unstructured":"Kelly, C. A. et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics \u2014 a large multicentre UK study. Rheumatology 53, 1676\u20131682\u00a0(2014).","journal-title":"Rheumatology"},{"key":"1394_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11102018","volume":"11","author":"S Di Vincenzo","year":"2022","unstructured":"Di Vincenzo, S. et al. Cigarette smoke impairs airway epithelial wound repair: role of modulation of epithelial-mesenchymal transition processes and Notch-1 signaling. Antioxidants 11, 2018 (2022).","journal-title":"Antioxidants"},{"key":"1394_CR51","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.40904","volume":"71","author":"JA Sparks","year":"2019","unstructured":"Sparks, J. A. et al. Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol. 71, 1472\u20131482 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1394_CR52","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.42162","volume":"74","author":"PA Juge","year":"2022","unstructured":"Juge, P. A. et al. A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 74, 1755\u20131765 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1394_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152729","volume":"73","author":"SH Chang","year":"2025","unstructured":"Chang, S. H. et al. Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: the prospective KORAIL cohort. Semin. Arthritis Rheum. 73, 152729 (2025).","journal-title":"Semin. Arthritis Rheum."},{"key":"1394_CR54","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","volume":"14","author":"VM Holers","year":"2018","unstructured":"Holers, V. M. et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat. Rev. Rheumatol. 14, 542\u2013557 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1394_CR55","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard.2009.120899","volume":"70","author":"H K\u00e4llberg","year":"2011","unstructured":"K\u00e4llberg, H. et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann. Rheum. Dis. 70, 508\u2013511 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"1394_CR56","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/ard.2009.114694","volume":"69","author":"P Stolt","year":"2010","unstructured":"Stolt, P. et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann. Rheum. Dis. 69, 1072\u20131076 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1394_CR57","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/art.38066","volume":"65","author":"VC Willis","year":"2013","unstructured":"Willis, V. C. et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum. 65, 2545\u20132554 (2013).","journal-title":"Arthritis Rheum."},{"key":"1394_CR58","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard, C. et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann. Rheum. Dis. 76, 1700\u20131706 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1394_CR59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12016-020-08819-0","volume":"60","author":"RX Chen","year":"2021","unstructured":"Chen, R. X. et al. Distinctive clinical characteristics and outcome of ILD-onset rheumatoid arthritis and ACPA-positive ILD: a longitudinal cohort of 282 cases. Clin. Rev. Allergy Immunol. 60, 46\u201354 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"1394_CR60","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1183\/23120541.00633-2020","volume":"7","author":"MP Mohning","year":"2021","unstructured":"Mohning, M. P. et al. Duration of rheumatoid arthritis and the risk of developing interstitial lung disease. ERJ Open Res. 7, 633\u20132020 (2021).","journal-title":"ERJ Open Res."},{"key":"1394_CR61","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0210-2022","volume":"32","author":"GM Joy","year":"2023","unstructured":"Joy, G. M. et al. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur. Respir. Rev. 32, 220210 (2023).","journal-title":"Eur. Respir. Rev."},{"key":"1394_CR62","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1164\/rccm.202206-1041ST","volume":"206","author":"V Cottin","year":"2022","unstructured":"Cottin, V. et al. Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT research statement. Am. J. Respir. Crit. Care Med. 206, E7\u2013E41 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1394_CR63","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3904\/kjim.2024.148","volume":"40","author":"Y Bin Joo","year":"2025","unstructured":"Bin Joo, Y. et al. Association of peripheral leukocyte telomere length with patients with rheumatoid arthritis with a focus on interstitial lung disease. Korean J. Intern. Med. 40, 676\u2013686 (2025).","journal-title":"Korean J. Intern. Med."},{"key":"1394_CR64","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00587-2025","volume":"66","author":"K El Husseini","year":"2025","unstructured":"El Husseini, K. et al. Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease. Eur. Respir. J. 66, 2500587 (2025).","journal-title":"Eur. Respir. J."},{"key":"1394_CR65","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00441-2023","volume":"62","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur. Respir. J. 62, 2300441 (2023).","journal-title":"Eur. Respir. J."},{"key":"1394_CR66","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.chest.2019.12.005","volume":"157","author":"JJ Solomon","year":"2020","unstructured":"Solomon, J. J. et al. IgA antibodies directed against citrullinated protein antigens are elevated in patients with idiopathic pulmonary fibrosis. Chest 157, 1513\u20131521 (2020).","journal-title":"Chest"},{"key":"1394_CR67","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3899\/jrheum.200863","volume":"48","author":"VL Kronzer","year":"2021","unstructured":"Kronzer, V. L. et al. Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease. J. Rheumatol. 48, 656\u2013663 (2021).","journal-title":"J. Rheumatol."},{"key":"1394_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/acr.25432","volume":"77","author":"GC McDermott","year":"2025","unstructured":"McDermott, G. C. et al. Impact of sex, serostatus, and smoking on risk for rheumatoid arthritis-associated interstitial lung disease subtypes. Arthritis Care Res. 77, 185\u2013194 (2025).","journal-title":"Arthritis Care Res."},{"key":"1394_CR69","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1164\/rccm.202109-2087LE","volume":"205","author":"SM Matson","year":"2022","unstructured":"Matson, S. M. et al. Prospective identification of subclinical interstitial lung disease in a rheumatoid arthritis cohort is associated with the MUC5B promoter variant. Am. J. Respir. Crit. Care Med. 205, 473\u2013476 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1394_CR70","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.chest.2020.04.061","volume":"158","author":"L Kawano-Dourado","year":"2020","unstructured":"Kawano-Dourado, L. et al. Baseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritis. Chest 158, 1546\u20131554 (2020).","journal-title":"Chest"},{"key":"1394_CR71","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"Gochuico, B. R. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch. Intern. Med. 168, 159\u2013166 (2008).","journal-title":"Arch. Intern. Med."},{"key":"1394_CR72","first-page":"344","volume":"56","author":"JA Zamora-Legoff","year":"2017","unstructured":"Zamora-Legoff, J. A., Krause, M. L., Crowson, C. S., Ryu, J. H. & Matteson, E. L. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology 56, 344\u2013350 (2017).","journal-title":"Rheumatology"},{"key":"1394_CR73","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semarthrit.2020.08.015","volume":"50","author":"S Huang","year":"2020","unstructured":"Huang, S. et al. Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: prevalence, risk factors, and impact on mortality. Semin. Arthritis Rheum. 50, 1216\u20131225 (2020).","journal-title":"Semin. Arthritis Rheum."},{"key":"1394_CR74","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003491","volume":"9","author":"PA Juge","year":"2023","unstructured":"Juge, P. A. et al. Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database. RMD Open 9, e003491 (2023).","journal-title":"RMD Open"},{"key":"1394_CR75","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz, T. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 62, 1583\u20131591 (2010).","journal-title":"Arthritis Rheum."},{"key":"1394_CR76","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon, J. J. et al. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur. Respir. J. 47, 588\u2013596 (2016).","journal-title":"Eur. Respir. J."},{"key":"1394_CR77","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.semarthrit.2019.04.005","volume":"49","author":"N Singh","year":"2019","unstructured":"Singh, N. et al. Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: a systematic literature review and meta-analysis. Semin. Arthritis Rheum. 49, 358\u2013365 (2019).","journal-title":"Semin. Arthritis Rheum."},{"key":"1394_CR78","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu, G. et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am. J. Respir. Crit. Care Med. 205, E18\u2013E47 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1394_CR79","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02776-2021","volume":"60","author":"P Spagnolo","year":"2022","unstructured":"Spagnolo, P., Bonniaud, P., Rossi, G., Sverzellati, N. & Cottin, V. Drug-induced interstitial lung disease. Eur. Respir. J. 60, 2102776 (2022).","journal-title":"Eur. Respir. J."},{"key":"1394_CR80","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/art.42861","volume":"76","author":"SR Johnson","year":"2024","unstructured":"Johnson, S. R. et al. 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Rheumatol. 76, 1182\u20131200 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1394_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-06005-z","volume":"45","author":"E Blomberg","year":"2025","unstructured":"Blomberg, E., Wahlin, B. & S\u00f6dergren, A. Comparable area under the curve for three risk scores to detect interstitial lung disease in patients with rheumatoid arthritis: an external validation. Rheumatol. Int. 45, 252 (2025).","journal-title":"Rheumatol. Int."},{"key":"1394_CR82","doi-asserted-by":"publisher","first-page":"e851","DOI":"10.1016\/S2665-9913(25)00158-4","volume":"7","author":"GC McDermott","year":"2025","unstructured":"McDermott, G. C. et al. Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA. Lancet Rheumatol. 7, e851\u2013e863\u00a0(2025).","journal-title":"Lancet Rheumatol."},{"key":"1394_CR83","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","volume":"66","author":"R Conway","year":"2014","unstructured":"Conway, R., Low, C., Coughlan, R. J., O\u2019Donnell, M. J. & Carey, J. J. Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheumatol. 66, 803\u2013812 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"1394_CR84","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/rheumatology\/keaa327","volume":"60","author":"EH Ibfelt","year":"2021","unstructured":"Ibfelt, E. H. et al. Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study. Rheumatology 60, 346\u2013352 (2021).","journal-title":"Rheumatology"},{"key":"1394_CR85","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","volume":"36","author":"J Rojas-Serrano","year":"2017","unstructured":"Rojas-Serrano, J. et al. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Clin. Rheumatol. 36, 1493\u20131500 (2017).","journal-title":"Clin. Rheumatol."},{"key":"1394_CR86","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00337-2020","volume":"57","author":"PA Juge","year":"2021","unstructured":"Juge, P. A. et al. Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur. Respir. J. 57, 2000337 (2021).","journal-title":"Eur. Respir. J."},{"key":"1394_CR87","doi-asserted-by":"publisher","first-page":"S685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann. Rheum. Dis. 79, S685\u2013S699 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1394_CR88","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","volume":"11","author":"JJ Solomon","year":"2023","unstructured":"Solomon, J. J. et al. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir. Med. 11, 87\u201396 (2023).","journal-title":"Lancet Respir. Med."},{"key":"1394_CR89","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","volume":"392","author":"TM Maher","year":"2025","unstructured":"Maher, T. M. et al. Nerandomilast in patients with progressive pulmonary fibrosis. N. Engl. J. Med. 392, 2203\u20132214 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1394_CR90","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty, K. R. et al. Nintedanib in progressive fibrosing interstitial lung diseases. N. Engl. J. Med. 381, 1718\u20131727 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1394_CR91","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.healun.2021.07.014","volume":"40","author":"MM Crespo","year":"2021","unstructured":"Crespo, M. M. et al. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements. J. Heart Lung Transplant. 40, 1251\u20131266 (2021).","journal-title":"J. Heart Lung Transplant."},{"key":"1394_CR92","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jtho.2023.10.006","volume":"19","author":"MH Cho","year":"2024","unstructured":"Cho, M. H. et al. Rheumatoid arthritis and risk of lung cancer: a nationwide cohort study. J. Thorac. Oncol. 19, 216\u2013226 (2024).","journal-title":"J. Thorac. Oncol."},{"key":"1394_CR93","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/S2665-9913(24)00379-5","volume":"7","author":"JI Ruiz","year":"2025","unstructured":"Ruiz, J. I. et al. Survival in patients with rheumatoid arthritis and recently diagnosed early-stage colorectal, lung, or prostate cancer receiving tumour necrosis factor inhibitors: a retrospective cohort study. Lancet Rheumatol. 7, e333\u2013e342 (2025).","journal-title":"Lancet Rheumatol."},{"key":"1394_CR94","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1093\/rheumatology\/keaf092","volume":"64","author":"S Ahmed","year":"2025","unstructured":"Ahmed, S. et al. Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis. Rheumatology 64, 4172\u20134180 (2025).","journal-title":"Rheumatology"},{"key":"1394_CR95","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-005247","volume":"11","author":"R Westermann","year":"2025","unstructured":"Westermann, R. et al. Cancer recurrence risk with bDMARD treatment in patients with rheumatoid arthritis and a history of cancer: a nationwide Danish register-based cohort study. RMD Open. 11, e005247 (2025).","journal-title":"RMD Open."},{"key":"1394_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0728-9","volume":"17","author":"TA Simon","year":"2015","unstructured":"Simon, T. A., Thompson, A., Gandhi, K. K., Hochberg, M. C. & Suissa, S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res. Ther. 17, 1 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"1394_CR97","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1016\/S2665-9913(23)00064-4","volume":"5","author":"KR McCarter","year":"2023","unstructured":"McCarter, K. R. et al. Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study. Lancet Rheumatol. 5, e274\u2013e283 (2023).","journal-title":"Lancet Rheumatol."},{"key":"1394_CR98","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.reuma.2011.09.004","volume":"8","author":"H G\u00f3mez Herrero","year":"2012","unstructured":"G\u00f3mez Herrero, H., Arraiza Sarasa, M., Rubio Marco, I. & de Eulate Mart\u00edn-Moro, G. N\u00f3dulos pulmonares reumatoides: forma de presentaci\u00f3n, m\u00e9todos diagn\u00f3sticos y evoluci\u00f3n, a prop\u00f3sito de 5 casos. Reumatol. Clin. 8, 212\u2013215 (2012).","journal-title":"Reumatol. Clin."},{"key":"1394_CR99","first-page":"1","volume":"2020","author":"G Wickrematilake","year":"2020","unstructured":"Wickrematilake, G. Complicated rheumatoid nodules in lung. Case Rep. Rheumatol. 2020, 1\u20133 (2020).","journal-title":"Case Rep. Rheumatol."},{"key":"1394_CR100","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3899\/jrheum.080557","volume":"36","author":"G Derot","year":"2009","unstructured":"Derot, G., Marini-Portugal, A., Maitre, B. & Claudepierre, P. Marked regression of pulmonary rheumatoid nodules under etanercept therapy. J. Rheumatol. 36, 437\u2013439 (2009).","journal-title":"J. Rheumatol."},{"key":"1394_CR101","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1136\/annrheumdis-2011-200915","volume":"71","author":"B Glace","year":"2012","unstructured":"Glace, B. et al. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab\/Rheumatoid Arthritis registry (AIR\/PR registry. Ann. Rheum. Dis. 71, 1429\u20131431 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"1394_CR102","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/rheumatology\/ker455","volume":"51","author":"M Andres","year":"2012","unstructured":"Andres, M., Vela, P. & Romera, C. Marked improvement of lung rheumatoid nodules after treatment with tocilizumab. Rheumatology 51, 1132\u20131134 (2012).","journal-title":"Rheumatology"},{"key":"1394_CR103","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10067-023-06773-8","volume":"43","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review. Clin. Rheumatol. 43, 775\u2013784 (2024).","journal-title":"Clin. Rheumatol."},{"key":"1394_CR104","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.4187\/respcare.02597","volume":"59","author":"JP Corcoran","year":"2014","unstructured":"Corcoran, J. P., Ahmad, M., Mukherjee, R. & Redmond, K. C. Pleuro-pulmonary complications of rheumatoid arthritis. Respir. Care 59, e55\u2013e59 (2014).","journal-title":"Respir. Care"},{"key":"1394_CR105","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1056\/NEJM196612152752404","volume":"275","author":"WH Dodson","year":"1966","unstructured":"Dodson, W. H. & Hollingsworth, J. W. Pleural effusion in rheumatoid arthritis. N. Engl. J. Med. 275, 1337\u20131342 (1966).","journal-title":"N. Engl. J. Med."},{"key":"1394_CR106","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00005792-196811000-00003","volume":"47","author":"WC Walker","year":"1968","unstructured":"Walker, W. C. & Wright, V. Pulmonary lesions and rheumatoid arthritis. Medicine 47, 501\u2013520 (1968).","journal-title":"Medicine"},{"key":"1394_CR107","first-page":"471","volume":"119","author":"GW Hunninghake","year":"1979","unstructured":"Hunninghake, G. W. & Fauci, A. S. Pulmonary involvement in the collagen vascular diseases. Am. Rev. Respir. Dis. 119, 471\u2013503 (1979).","journal-title":"Am. Rev. Respir. Dis."},{"key":"1394_CR108","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.62.8.722","volume":"62","author":"C Turesson","year":"2003","unstructured":"Turesson, C., O\u2019Fallon, W. M., Crowson, C. S., Gabriel, S. E. & Matteson, E. L. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann. Rheum. Dis. 62, 722\u2013727 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"1394_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051082","volume":"13","author":"D Wu","year":"2022","unstructured":"Wu, D. et al. Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment. Front. Immunol. 13, 1051082 (2022).","journal-title":"Front. Immunol."},{"key":"1394_CR110","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.semarthrit.2006.03.002","volume":"35","author":"A Balbir-Gurman","year":"2006","unstructured":"Balbir-Gurman, A., Yigla, M., Nahir, A. M. & Braun-Moscovici, Y. Rheumatoid pleural effusion. Semin. Arthritis Rheum. 35, 368\u2013378 (2006).","journal-title":"Semin. Arthritis Rheum."},{"key":"1394_CR111","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00296-007-0322-9","volume":"27","author":"LS Avnon","year":"2007","unstructured":"Avnon, L. S., Abu-Shakra, M., Flusser, D., Heimer, D. & Sion-Vardy, N. Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate. Rheumatol. Int. 27, 919\u2013925 (2007).","journal-title":"Rheumatol. Int."},{"key":"1394_CR112","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/cyt.13450","volume":"36","author":"E Viljanen","year":"2025","unstructured":"Viljanen, E., Kholov\u00e1, I. & Chandra, A. Practical approach to reporting based on the international system for serous fluid cytopathology. Cytopathology 36, 12\u201322 (2025).","journal-title":"Cytopathology"},{"key":"1394_CR113","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1164\/ajrccm\/138.1.184","volume":"138","author":"SA Sahn","year":"1988","unstructured":"Sahn, S. A. State of the art. The pleura. Am. Rev. Respir. Dis. 138, 184\u2013234 (1988).","journal-title":"Am. Rev. Respir. Dis."},{"key":"1394_CR114","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000119051","volume":"75","author":"D Bouros","year":"2008","unstructured":"Bouros, D., Pneumatikos, I. & Tzouvelekis, A. Pleural involvement in systemic autoimmune disorders. Respiration 75, 361\u2013371 (2008).","journal-title":"Respiration"},{"key":"1394_CR115","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/PAS.0000000000002374","volume":"49","author":"W Klaisuban","year":"2025","unstructured":"Klaisuban, W. et al. Revisit of histopathology in rheumatoid lung nodules. Am. J. Surg. Pathol. 49, 588\u2013593 (2025).","journal-title":"Am. J. Surg. Pathol."},{"key":"1394_CR116","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.ejrad.2015.07.008","volume":"84","author":"T Chansakul","year":"2015","unstructured":"Chansakul, T., Dellaripa, P. F., Doyle, T. J. & Madan, R. Intra-thoracic rheumatoid arthritis: imaging spectrum of typical findings and treatment related complications. Eur. J. Radiol. 84, 1981\u20131991 (2015).","journal-title":"Eur. J. Radiol."},{"key":"1394_CR117","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/RHU.0000000000000244","volume":"21","author":"A Komarla","year":"2015","unstructured":"Komarla, A., Yu, G. H. & Shahane, A. Pleural effusion, pneumothorax, and lung entrapment in rheumatoid arthritis. J. Clin. Rheumatol. 21, 211\u2013215 (2015).","journal-title":"J. Clin. Rheumatol."},{"key":"1394_CR118","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.10879","volume":"202","author":"R Madan","year":"2014","unstructured":"Madan, R. & Chick, J. F. B. Spectrum of radiologic appearances of surgical thoracostomy and thoracoplasty in the treatment of pleuroparenchymal infections. Am. J. Roentgenol. 202, 2 (2014).","journal-title":"Am. J. Roentgenol."},{"key":"1394_CR119","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.chest.2024.11.038","volume":"167","author":"M Otaola","year":"2025","unstructured":"Otaola, M. et al. Performance of lung ultrasound as a screening tool for subclinical rheumatoid arthritis-associated interstitial lung disease: a multicenter study. Chest 167, 1687\u20131695 (2025).","journal-title":"Chest"},{"key":"1394_CR120","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/ard-2022-223335","volume":"82","author":"GE Fragoulis","year":"2023","unstructured":"Fragoulis, G. E. et al. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann. Rheum. Dis. 82, 742\u2013753 (2023).","journal-title":"Ann. Rheum. Dis."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01394-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01394-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01394-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:02:26Z","timestamp":1787313746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01394-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":120,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1038\/s41584-026-01394-2","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"19 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}